Ivana Magovcevic-Liebisch

Sits on 3 boards. Last updated September 28, 2026

Time on boards

Boards served
3
Current seats
3
Board service
8 years
Director since
2023

8 years of board service in total across 3 boards, counting each seat separately. Longest: Spyre Therapeutics Inc., 3 years.

3 years · Since 2023
2 years · Since 2024
2 years · Since 2024

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Oct 2, 2026 Quanterix Corporation Option exercise +4,224 — —
May 18, 2026 Acrivon Therapeutics Inc. Grant or award +9,366 — —
Jan 2, 2026 Quanterix Corporation Grant or award +23,372 — —
Jan 2, 2025 Quanterix Corporation Grant or award +7,435 — —
Oct 2, 2024 Quanterix Corporation Grant or award +12,800 — —

Questions about Ivana Magovcevic-Liebisch

What boards is Ivana Magovcevic-Liebisch on?

Ivana Magovcevic-Liebisch sits on the boards of Acrivon Therapeutics Inc., Quanterix Corporation and Spyre Therapeutics Inc.

How long has Ivana Magovcevic-Liebisch served on boards?

Our records show at least 8 years of board service across 3 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.